DrugPatentWatch Database Preview
Details for Patent: 9,155,716
» See Plans and Pricing
Which drugs does patent 9,155,716 protect, and when does it expire?
Patent 9,155,716 protects LUMIGAN and is included in one NDA.
This patent has thirty-four patent family members in twenty-two countries.
Summary for Patent: 9,155,716
| Title: | Enhanced bimatoprost ophthalmic solution |
| Abstract: | A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. |
| Inventor(s): | Chang; Chin-Ming (Tustin, CA), Chang; James N. (Newport Beach, CA), Schiffman; Rhett M. (Laguna Beach, CA), Jordan; R. Scott (Trabuco Canyon, CA), Chang-Lin; Joan-En (Tustin, CA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 13/826,047 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,155,716 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,155,716
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Y | A METHOD OF LOWERING INTRAOCULAR PRESSURE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,155,716
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 055050 | Start Trial | |||
| Austria | 431152 | Start Trial | |||
| Australia | 2006227757 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
